The aim of this study was to determine the prevalence of advanced hepatic fibrosis and to individualize using Bayesian analysis its associated risk factors in patients with metabolic dysfunction-assoc
AUC area under ROC curve, CI confident interval, APACHE II acute physiology and chronic health evaluation II scoring system, P value tests the null hypothesis that the AUC really equals 0.5. * no sign